Home
Resources
Publications
GYKI 52466 Blocks the Increase in Extracellular Glutamate Induced by Ischaemia

GYKI 52466 Blocks the Increase in Extracellular Glutamate Induced by Ischaemia

B Arvin, C Moncada, E Le Peillet, A Chapman, B S Meldrum

Neuroreport. 1992 Mar;3(3):235-8.

PMID: 1355369

Abstract:

In vivo microdialysis has been used to study the effect of pre- or post-ischaemic administration of the non-NMDA antagonist 1-(4-amino-phenyl)-4-methyl-7, 8-methyl-endioxyl-5H-2,3- benzodiazepine hydrochloride (GYKI 52466), on the increases in extracellular glutamate levels induced by 20 minutes of four vessel occlusion in rats. In control rats, ischaemia resulted in transient increases in glutamate (4 fold), aspartate (6 fold) and gamma-aminobutyric acid (GABA) (15 fold) and decreases in glutamine (0.5 fold). Intravenous administration of GYKI 52466 (10 mg kg-1 bolus followed by 10 mg kg-1 h-1 infusion) beginning 20 minutes prior to the induction of ischaemia abolished ischaemia-induced glutamate release without affecting the increases in aspartate and GABA and the decrease in glutamine. Administration of GYKI 52466 immediately post-ischaemia resulted in a more rapid return of glutamate levels to basal values.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP192065568	GYKI 52466 hydrochloride		192065-56-8	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: